Olumiant 2 mg
Olumiant 2 mg is a medicine authorised by Swissmedic under authorisation number 66215. The authorisation holder is Eli Lilly (Suisse) SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 June 2017 and the authorisation is valid without a time limit. ATC code L04AA37 places the medicine in the group Immunosuppressants.
| Authorisation number | 66215 |
|---|---|
| Name | Olumiant 2 mg |
| Full name | Olumiant 2 mg, comprimés pelliculés |
| Authorisation holder | Eli Lilly (Suisse) SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AA37 |
| First authorisation | 19 June 2017 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Olumiant 2 mg, comprimés pelliculés | B | 19 June 2017 |
| 2 | Olumiant 4 mg, comprimés pelliculés | B | 19 June 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | L04AA37 | 07.15.0. | B |
| 2 | 28 | Tablette(n) | L04AA37 | 07.15.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Olumiant 2 mg authorised in Switzerland?
Yes. Olumiant 2 mg is authorised by Swissmedic under authorisation number 66215, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Olumiant 2 mg have?
Olumiant 2 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Olumiant 2 mg?
The authorisation holder is Eli Lilly (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.